Meilleure Health International Industry Group Limited announced the cancellation of 33.07 million previously-repurchased ordinary shares on 1 June 2026, reducing its outstanding share count by approximately 0.81 % from 4.09 billion to 4.06 billion shares (excluding treasury shares).

The cancelled shares stem from 12 separate buy-back transactions executed between July 2023 and January 2026 at repurchase prices ranging from HKD 0.2127 to HKD 0.3017 per share. The weighted-average repurchase cost is estimated at roughly HKD 0.30 per share, implying an aggregate buy-back consideration of about HKD 9.77 million.

Post-cancellation, the company’s issued share capital comprises 4.06 billion ordinary shares, of which 5.33 million remain as treasury shares. No additional repurchased shares are pending cancellation as at the reporting date.